Cognitive Effects of Atomoxetine in Humans: Genetic Moderators
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The overall goal of this study is to determine if atomoxetine treatment improves selective
cognitive functions in abstinent cocaine users, compared to healthy controls. The study will
also test if a functional variation of the NET promoter polymorphic region (NETpPR) moderates
the cognitive effects of atomoxetine.